Intravenous injection of autologous bone marrow-derived mesenchymal stem cells on the gene expression and plasma level of CCL5 in refractory rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA) is the most prevalent autoimmune disease, in which CCL2 and CCL5 are critically involved. The objective was to evaluate the therapeutic effects of bone marrow-derived mesenchymal stem cells (MSCs) on the foregoing chemokines in RA patients. MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi, Mina, Tavakkol-Afshari, Jalil, Shariati-Sarabi, Zhaleh, Shabgah, Arezoo Gowhari, Ghoryani, Mohsen, Ghasemi, Ali, Mohammadi, Mojgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067892/
https://www.ncbi.nlm.nih.gov/pubmed/33912221
http://dx.doi.org/10.4103/jrms.JRMS_308_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067892/
https://www.ncbi.nlm.nih.gov/pubmed/33912221
http://dx.doi.org/10.4103/jrms.JRMS_308_20

Ejemplares similares